MedPath
FDA Approval

Albendazole

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
September 30, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Albendazole(200 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

GlaxoSmithKline Inc.

Amneal Pharmaceuticals of New York LLC

205556368

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Albendazole

Product Details

NDC Product Code
0115-1701
Application Number
NDA020666
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
September 30, 2019
Code: F4216019LNClass: ACTIBQuantity: 200 mg in 1 1
CARNAUBA WAXInactive
Code: R12CBM0EIZClass: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
SACCHARIN SODIUM MONOHYDRATEInactive
Code: A9CO00M9HVClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
© Copyright 2025. All Rights Reserved by MedPath